1·In clinical practice, there are several kinds of oral antidiabetic agents (OADs) helping patients regulate blood glucose level besides insulin.
在临床实践中，除了皮下注射胰岛素之外，还有各种口服降糖药帮助患者控制血糖水平。
2·Oral antidiabetic drugs are the main measurement among all of the treatment, therefore, rational usage of oral antidiabetic drugs appears more important.
而在所有治疗中口服降糖药是主要手段，因此，后者的合理应用显得尤为重要。
3·When initiating oral antidiabetic therapy in newly diagnosed T2DM patients, physicians always recommend to use metformin over sulfonylureas.
医生最初应用口服降糖药治疗新诊断2型糖尿病时，往往被建议应用二甲双胍而非磺脲类。
4·Overall, 27% of participants had not received prior treatment for their diabetes, 67% were on oral antidiabetic drugs alone, and 6% were receiving insulin with or without oral antidiabetic drugs.
在IMPROVE研究中，27%的患者在此之前未接受过糖尿病治疗，67%的患者仅使用口服降糖药物治疗，6%的患者使用胰岛素治疗(其中部分患者同时使用口服降糖药治疗)。
5·And we now have attained considerable success in controlling blood glucose and delaying chronic complications by oral antidiabetic agents (OADs) as well as insulin injection.
现在我们通过口服降糖药和胰岛素在控制血糖及延缓慢性并发症上以获得相当的成功。
1·In order to look for new antidiabetic compounds, we have improved the method of isolating mangiferin and studied on structure modification of mangiferin.
为了寻找新的抗糖尿病化合物，我们改进了知母中芒果苷的提取分离工艺，并对芒果苷进行了结构修饰研究。
2·Methods to analyze and sum up the use of the oral antidiabetic agents in our hospital from 2001 to 2004 by using the methods of DDDs analysis and ranking of amount of money.
方法采用金额排序法和频度分析法对我院2001 ~ 2004年口服抗糖尿病药物应用情况进行统计分析。
3·CONCLUSIONS - Bezafibrate appears to have clinically important antidiabetic properties.
结论：苯扎贝特表现出很重要的临床抗糖尿病属性。
4·A post hoc analysis was used to examine the effect of bezafibrate on progression to use of oral antidiabetic medications or insulin in individuals with diabetes at baseline.
采用事后分析以口服抗糖尿病药或胰岛素做基准检测苯扎贝特的效果。